Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079).
| Image |  |
|---|---|
| Description | scientific article published on 19 June 2015 |
| Author/s |
author: Wan-Teck Lim Herbert Loong Kwok Wai Lo Brigette Ma Ann D King Leung Li Charles Erlichman |
| Publication date | June 19, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |